Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
LY2886721 BACE Inhibitor Research Workflows
2026-08-17
LY2886721 supports controlled BACE1 enzyme inhibition across biochemical, neuronal, and transgenic-mouse workflows. Its strongest use-case is pairing amyloid beta reduction with synaptic-function measurements to identify exposure levels that alter APP processing without overinterpreting a single biomarker.
-
nPEC for Dual-Loaded Liposome Encapsulation
2026-08-17
Yuan and colleagues compared six separation strategies for measuring the encapsulation efficiency of dual-loaded liposomes containing hydrophilic and lipophilic drugs. Their validated nanoparticle exclusion chromatography approach enabled simultaneous online HPLC analysis and offered a broadly applicable alternative to more laborious or formulation-specific methods.
-
Cisapride in iPSC-CM Cardiotoxicity Workflows
2026-08-16
Cisapride, also known as R 51619, connects 5-HT4 receptor biology with hERG channel inhibition in practical cardiac safety workflows. Use it as a mechanistic challenge compound for iPSC-derived cardiomyocyte imaging, electrophysiology, and orthogonal cardiac arrhythmia research.
-
Octenidine Dihydrochloride Research Workflows
2026-08-15
Build reproducible antimicrobial screens around octenidine dihydrochloride with controlled stock preparation, membrane-disruption readouts, and matrix-aware troubleshooting. The workflow also shows how recent gemini quaternary ammonium research can guide bacterial, biofilm, fungal, and carefully bounded comparative assays.
-
HyperScript™ Reverse Transcriptase for qPCR
2026-08-14
HyperScript™ Reverse Transcriptase is designed for difficult RNA-to-cDNA workflows, including structured transcripts, long targets, and low-copy RNA detection. This practical guide connects its thermal stability and reduced RNase H activity to RT-qPCR assay design, using hepatocellular carcinoma research as an applied example.
-
Sex Differences in Angiotensin II Hypertension
2026-08-14
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II infusion produces a substantially larger hypertensive response in male than female conscious mice. Telemetry, gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent autonomic and hormonal regulation rather than baseline blood pressure differences.
-
3X (DYKDDDDK) Peptide Workflow Guide
2026-08-13
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-based detection, competitive elution, and assay validation across recombinant protein workflows. This guide connects practical 3X FLAG peptide use with V-ATPase complex studies, metal-sensitive assays, and structural biology troubleshooting.
-
ECL Chemiluminescent Substrate Detection Kit
2026-08-13
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, is intended for HRP-based immunoblotting when standard detection lacks sufficient sensitivity for low-abundance proteins. It is appropriate for research use with nitrocellulose or PVDF membranes, but its dossier specifications should not be interpreted as independently validated diagnostic performance or as a substitute for assay-specific optimization.
-
HyperScript™ Reverse Transcriptase for qPCR
2026-08-12
HyperScript™ Reverse Transcriptase is designed for difficult RNA to cDNA conversion, including structured transcripts, long targets, and low-copy messages. This workflow shows how to apply its thermal stability and reduced RNase H activity to reproducible qPCR assay development and cancer-biology research.
-
AG-490: JAK2/STAT6 Research Workflow
2026-08-12
Use AG-490 (Tyrphostin B42) to test whether exosomal signals drive macrophage polarization through JAK2-linked signaling. This practical workflow combines exosome exposure, phosphoprotein analysis, flow cytometry, and troubleshooting controls for cancer research and immune-signaling studies.
-
PRDX5 Acetylation in Retinal Ischemia–Reperfusion
2026-08-11
This study identifies PRDX5 acetylation as a regulatory layer that weakens the protein’s antioxidant and anti-apoptotic activity during retinal ischemia-reperfusion injury. By combining an acute high intraocular pressure mouse model with OGD/R-treated R28 cells, the authors connect PRDX5 expression and acetylation to oxidative stress, mitochondrial dysfunction, and retinal neuronal apoptosis.
-
PKM2 inhibitor (compound 3k) Workflow Guide
2026-08-11
Build a rigorous PKM2-centered workflow that links glycolytic flux, cancer-cell viability, and macrophage state. This guide combines product-specific handling with the USP7–PKM2 evidence base to support oncology and immunometabolism experiments while clearly separating validated findings from recommended starting conditions.
-
Oseltamivir Acid: Designing Translational Assays
2026-08-10
Oseltamivir acid is an influenza neuraminidase inhibitor with applications spanning viral release assays and exploratory oncology models. This guide presents an assay-centered framework for connecting mechanism, solubility, resistance, metabolism, and translational decision-making without overstating the evidence.
-
Thiazovivin (A5506): ROCK Inhibitor Workflow
2026-08-09
Thiazovivin (SKU A5506) is a ROCK inhibitor used to support fibroblast reprogramming and improve human embryonic stem cell survival after trypsinization. This guide covers preparation, controls, handling, and troubleshooting, while emphasizing that concentration, exposure time, and clinical use must be established independently for each laboratory workflow.
-
(S)-(+)-Dimethindene maleate: Protocol Guide
2026-08-08
This guide describes how to use (S)-(+)-Dimethindene maleate as an M2 muscarinic receptor antagonist while accounting for its additional histamine H1 antagonism. It is intended for controlled pharmacology experiments, not diagnostic, therapeutic, or clinical use, and should be handled as a fresh solution rather than a long-term stock.